发明名称 alpha v beta 3 INTEGRIN AS A PREDICTOR OF ENDOMETRIOSIS
摘要 Methods of predicting endometriosis comprise obtaining a sample of endometrium selected from menstrual cycle day 20 to 24, identifying the endometrial sample as nulliparous, contacting the endometrium with a monoclonal antibody for beta 3 integrin, assaying for beta 3 integrin and correlating the absence of beta 3 integrin with endometriosis, wherein the endometrium is identified as mild/minimum endometriosis. A method of using monoclonal antibodies to predict endometriosis is also within the scope of the invention. Methods for detecting receptivity of mammalian endometrium to embryo implantation comprising obtaining a sample of the endometrium, contacting the endometrium with a monoclonal antibody for beta 3 and detecting beta 3 in the endometrium. The invention also provides for methods of diagnosing infertility in a mammal and methods of detecting the window of embryo implantation in endometrium. Methods of in vitro fertilization, methods of preventing embryo implantation and a method of monitoring endometrial maturation are also within the scope of the present invention. The present invention is also directed to contraceptives. Diagnostic kits useful in the practice of the methods of the invention are also provided.
申请公布号 WO9513821(A1) 申请公布日期 1995.05.26
申请号 WO1994US13299 申请日期 1994.11.18
申请人 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLANIA 发明人 LESSEY, BRUCE, A.
分类号 G01N33/53;A61D19/04;A61K35/48;A61K38/00;A61K39/395;A61K45/00;A61P13/02;A61P15/00;C07K16/06;C07K16/28;C12P21/08;G01N33/554;G01N33/567;G01N33/574;G01N33/577;G01N33/68;(IPC1-7):A61K35/48;G01N33/15;G01N33/543 主分类号 G01N33/53
代理机构 代理人
主权项
地址